ask="3.29"
ask_size="1000"
average_daily_volume="31673"
bid="N/A"
bid_size="N/A"
book_value="1.40"
change="-0.04"
change_from_200_day_moving_average="1.78"
change_from_50_day_moving_average="1.88"
change_from_52_week_high="-0.62"
change_From_52_week_low="2.15"
change_in_percent="-1.48%"
close="2.66"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.30"
ebitda="-2.11M"
eps_estimate_current_year="-0.02"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.02"
ex_dividend_date="N/A"
float_shares="2018000"
high="2.70"
high_52_weeks="3.28"
last_trade_date="2/14/2017"
last_trade_price="2.66"
last_trade_size="100"
last_trade_time="3:48pm"
low="2.58"
low_52_weeks="0.51"
market_capitalization="7.13M"
moving_average_200_day="0.88"
moving_average_50_day="0.78"
name="XTL Biopharmaceuticals Ltd."
notes="N/A"
one_year_target_price="30.00"
open="2.70"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+203.25%"
percent_change_from_50_day_moving_average="+241.42%"
percent_change_from_52_week_high="-18.90%"
percent_change_from_52_week_low="+421.57%"
previous_close="2.70"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.93"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="2680000"
short_ratio="0.45"
stock_exchange="NCM"
symbol="XTLB"
volume="13714"
weeks_range_52="0.51 - 3.28"
